Heron Therapeutics, Inc. (HRTX)
0.3115
-0.01
(-2.04%)
USD |
NASDAQ |
Sep 01, 16:00
0.3214
+0.01
(+3.18%)
After-Hours: 17:02
Heron Therapeutics Research and Development Expense (Annual) : 12.43M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 12.43M |
| December 31, 2024 | 16.68M |
| December 31, 2023 | 55.90M |
| December 31, 2022 | 103.31M |
| December 31, 2021 | 130.82M |
| December 31, 2020 | 174.53M |
| December 31, 2019 | 167.38M |
| December 31, 2018 | 140.03M |
| December 31, 2017 | 137.08M |
| December 31, 2016 | 96.42M |
| December 31, 2015 | 61.18M |
| December 31, 2014 | 54.83M |
| December 31, 2013 | 32.78M |
| December 31, 2012 | 15.04M |
| December 31, 2011 | 8.207M |
| December 31, 2010 | 7.264M |
| December 31, 2009 | 7.796M |
| December 31, 2008 | 19.51M |
| December 31, 2007 | 19.00M |
| Date | Value |
|---|---|
| December 31, 2006 | 14.84M |
| December 31, 2005 | 9.912M |
| December 31, 2004 | 11.11M |
| December 31, 2003 | 8.66M |
| December 31, 2002 | 6.699M |
| December 31, 2001 | 7.348M |
| December 31, 2000 | 3.713M |
| December 31, 1999 | 4.267M |
| December 31, 1998 | 4.382M |
| December 31, 1997 | 3.740M |
| December 31, 1996 | 3.506M |
| December 31, 1995 | 4.139M |
| December 31, 1994 | 6.334M |
| December 31, 1993 | 7.343M |
| December 31, 1992 | 3.726M |
| December 31, 1991 | 2.211M |
| December 31, 1990 | 2.916M |
| December 31, 1989 | 3.182M |
| December 31, 1988 | 3.635M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Praxis Precision Medicines, Inc. | 267.12M |
| Tonix Pharmaceuticals Holding Corp. | 44.49M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Anika Therapeutics, Inc. | 25.77M |